Loading organizations...
Loading organizations...
Develops topical hedgehog pathway inhibitor for basal cell carcinomas.
PellePharm has raised $90.0M across 2 funding rounds.
PellePharm has raised $90.0M in total across 2 funding rounds.
PellePharm has raised $90.0M in total across 2 funding rounds.
PellePharm's investors include Thorsten Thormann, PhD, Frank McCormick.
PellePharm has raised $90.0M across 2 funding rounds. Most recently, it raised $70.0M Other Equity in November 2018.
| Date | Round | Lead Investors | Other Investors |
|---|---|---|---|
| Nov 20, 2018 | $70.0M Other Equity | Thorsten Thormann, PhD | |
| Jul 31, 2017 | $20.0M Series B | Frank McCormick |